BMS Sues Mylan For $15M Over Improper HIV Drug Sales
Bristol-Myers Squibb Co. sued Mylan Inc. in New York on Monday for allegedly selling a generic version of HIV drug Reyataz in Venezuela, violating an agreement to sell the treatment in...To view the full article, register now.
Already a subscriber? Click here to view full article